Literature DB >> 1323608

CD3+4-8- alpha beta T cell population with biased T cell receptor V gene usage. Presence in bone marrow and possible involvement of IL-3 for their extrathymic development.

H Kubota1, H Okazaki, M Onuma, S Kano, M Hattori, N Minato.   

Abstract

Analysis of TCR of a series of CD4-8- (double negative; DN) alpha beta T cell lines induced with IL-3 revealed that their V gene usage was biased for V alpha 4 and V beta 2. This has been confirmed in the primary short-term cultures. Thus, IL-3 induced the generation of DN alpha beta T cells with predominant V beta 2 gene expression from the CD4+/CD8+ T cell-depleted spleen or bone marrow (BM) cells of both normal and nude BALB/c mice within 10 days. It was further indicated that the V beta 2+ beta-chain genes contained few junctional N regions in both IL-3-induced primary DN alpha beta T cells and continuous lines. Search for the in vivo counterpart of in vitro IL-3-induced DN alpha beta T cells revealed that BM, but not spleens, of normal BALB/c and B6 mice did contain a significant proportion of DN alpha beta T cells, and that the majority of them expressed V beta 2+ beta-chain genes with few junctional N regions. The presence of V beta 2+ DN alpha beta T cells was similarly observed in the BM of BALB/c nude mice, but their proportion varied markedly among various strains of mice, which was not linked to H-2 haplotypes. The results indicated that V beta 2+ DN alpha beta T cells in the BM represented one of the thymus-independent T cell populations, whose development was under the major histocompatibility Ag complex-unlinked genetic control. TCR of these T cells were shown to be functional as judged by the proliferative response to anti-V beta 2 antibody. Taken together, present results suggested that IL-3 could induce differentiation and/or proliferation of DN alpha beta T cells with uniquely limited repertoire, which existed preferentially in BM in vivo, and implied the possible involvement of extrathymic endogenous ligands as a positive selection force.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323608

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Double-negative regulatory T cells: non-conventional regulators.

Authors:  Christopher W Thomson; Boris P-L Lee; Li Zhang
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Occurrence of interleukin-5 production by CD4- CD8- (double-negative) T cells in lungs of both normal and congenitally athymic nude mice infected with Toxocara canis.

Authors:  M Takamoto; Y Kusama; K Takatsu; H Nariuchi; K Sugane
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

3.  Human T-cell receptor (TCR) alpha/beta + CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR V beta-gene families, and phenotypically resemble memory T cells.

Authors:  E G Brooks; S P Balk; K Aupeix; M Colonna; J L Strominger; V Groh-Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

4.  Definition of unique traits of human CD4-CD8- alpha beta T cells.

Authors:  J G Murison; S Quaratino; M Kahan; A Verhoef; M Londei
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

5.  Human alpha beta T-cell receptor CD4-CD8 T-cell clones are predominantly Th0-like.

Authors:  P D Katsikis; S B Cohen; J G Murison; J Uren; L M Hibbart; R E Callard; F Di Padova; M Feldmann; M Londei
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

6.  Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ IL-7R+ Thy1+ lympho-hemopoietic progenitors develop.

Authors:  Y Kanamori; K Ishimaru; M Nanno; K Maki; K Ikuta; H Nariuchi; H Ishikawa
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

Review 7.  NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function.

Authors:  H R MacDonald
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

8.  Combined approaches for drug design points the way to novel proline racemase inhibitor candidates to fight Chagas' disease.

Authors:  Armand Berneman; Lory Montout; Sophie Goyard; Nathalie Chamond; Alain Cosson; Simon d'Archivio; Nicolas Gouault; Philippe Uriac; Arnaud Blondel; Paola Minoprio
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells.

Authors:  P Dellabona; E Padovan; G Casorati; M Brockhaus; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

10.  In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset.

Authors:  P Dellabona; G Casorati; B Friedli; L Angman; F Sallusto; A Tunnacliffe; E Roosneek; A Lanzavecchia
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.